baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

L&S Knock-Out FACC/ DE000LX2KFN4 /

2024-06-14 8:12:19 AM	Chg.-0.46	Bid10:00:39 PM	Ask10:00:39 PM	Underlying	Strike price	Expiration date	Option type
2.97EUR	-13.41%	- Bid Size: -	- Ask Size: -	FACC AG INH.AKT.	5.0939 -	2078-12-31	Call

GlobeNewswire 06-12 Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspect...

GlobeNewswire 06-10 Clinical ink Appoints Dr. Nicholas Alp, MD PhD FACC as Chief Medical Officer

GlobeNewswire 06-05 Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer

GlobeNewswire 06-04 Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Le...

GlobeNewswire 05-17 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine

GlobeNewswire 05-17 Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biol...

GlobeNewswire 05-16 CVRx Announces Key Senior Leadership Team Hires

GlobeNewswire 05-15 Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium

GlobeNewswire 05-15 HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REV...

GlobeNewswire 05-07 Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...

GlobeNewswire 05-07 Rugby Provides Exploration Update on its Gold-Silver Projects in Santa Cruz Province, Argentina

GlobeNewswire 05-02 Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stan...

GlobeNewswire 04-30 Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...

GlobeNewswire 04-23 Clinical ink announces GlucoseReady™

GlobeNewswire 04-08 Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage R...

GlobeNewswire 04-07 Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (...

GlobeNewswire 04-01 Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and Eu...

GlobeNewswire 03-27 Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Dr...

GlobeNewswire 03-25 Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & ...

GlobeNewswire 03-25 Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation

GlobeNewswire 03-13 Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Cent...

GlobeNewswire 03-12 HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journa...

GlobeNewswire 02-27 Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients wit...

GlobeNewswire 02-26 HeartSciences Adds Key Advisor to its Scientific Advisory Board

GlobeNewswire 02-22 RAJANT HEALTH’S CUTTING-EDGE WEARABLE RECEIVES MEDICAL EXPERT ENDORSEMENTS

L&S Knock-Out FACC/ DE000LX2KFN4 /

If you wish to receive reply to your feedback, please provide your email address.